Clinical trial
Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5…
NCT00169923 · Leiden University Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00169923 |
|---|---|
| Title | Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease |
| Official title | Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease |
| Acronym | Hercules |
| Lead sponsor | Leiden University Medical Center, Other |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Inflammation |
| Intervention type | Drug |
| Interventions | rosiglitazone |
| Enrollment | 200 |
| Start date | Apr 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 1, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: